Rchr
J-GLOBAL ID：201801013922231667   Update date: Sep. 01, 2024

Keiko Shuto

シュトウ ケイコ | Keiko Shuto
Research field  (1)： Cell biology
Research theme for competitive and other funds  (6)：
  • 2022 - 2025 SIGIRR/IL-18Rα複合体形成に基づいた新規抗炎症療法の分子基盤の確立
  • 2019 - 2022 Elucidation of the regulation mechanism of cystic fibrosis-specific splice variant expression and development of novel therapeutic strategies
  • 2016 - 2019 Therapeutic application to cystic fibrosis based on IL-37 and stabilized cell surface expression of SIGIRR
  • 2014 - 2016 Molecular basis of SIGIRR expression and regulatory function in Cystic Fibrosis and its therapeutic approach
  • 2010 - 2012 Regulatory mechanism of SIGIRR/TIR8 expressionn LPS-mediated signaling.
Show all
Papers (4)：
MISC (17)：
ｍore...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM